under 1 year old were vaccinated in The Gambia'" or in 1-15 year olds in Thailand." A further trial in infants is underway in Tanzania as this is the age group in Africa most at risk. While the concept of combining epitopes from different antigens and stages is a good one, this particular peptide is unlikely to be used outside South America, and even here will probably be superseded.
Multiple antigen-epitope-gene approach The multiple antigen-epitope-gene approach to malaria vaccine development is widely perceived as the only way to achieve good antiparasitic and disease immunity. An important element of such an approach is likely to be an immune response to the sexual cycle that begins with the male and female gametocytes produced in the blood and is completed within the feeding mosquito. In an article referred to by Stewart, Valente says candidly that one of the goals of proficiency testing is to "weed out the incompetent", although he points out that there is no evidence that proficiency testing improves laboratory performance.3 He also says that "common sense would indicate that the recognition of accepted diagnostic criteria is a valid measure of competence" and that "we must not lose sight of the education role of proficiency testing".' Stewart suggests that internal quality control, accreditation, and comparison of performance and outcome might equally or even better be able to identify poor performance. Is an external assessment needed as well?
Stewart must be justified in saying that there is no evidence that mortality from cervical cancer is affected by proficiency testing. Laboratory performance would have to be uniformly substandard for a long time to be reflected in mortality, which is difficult to compare in small populations. More to the point, he says that proficiency does not reflect laboratory false negative rates. Sensitivity of primary screening is proportional to the number of abnormalities known to be present4 and would be expected to be high in a set of 10 slides almost half of which were known to be abnormal. Sensitivity of primary screening can be monitored by re-screening negative slides, but ultimately 
